About one in nine Americans take a GLP-1 medication for weight loss, results from a new Gallup poll found—a staggering rise over the past two years as the obesity rate in the U.S. continues to decline from a record high in 2022.Read more: https://t.co/EqdLXp6BqWPhoto: Michael Siluk/UCG/Universal Images Group via Getty Images ...

While blockbuster GLP-1 drugs like Wegovy and Zepbound are known for helping people lose weight, a new wave of people are using them to treat their eating disorders instead. Success, for them, might actually involve gaining weight. 🔗 https://t.co/Ca6c1Oph1Z https://t.co/1cOQ2QOo6n ...